1
|
Mahmoudi N, Roque M, Paiva Dos Santos B, Oliveira H, Siadous R, Rey S, Garanger E, Lecommandoux S, Catros S, Garbay B, Amédée Vilamitjana J. An Elastin-Derived Composite Matrix for Enhanced Vascularized and Innervated Bone Tissue Reconstruction: From Material Development to Preclinical Evaluation. Adv Healthc Mater 2024:e2303765. [PMID: 38651610 DOI: 10.1002/adhm.202303765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Revised: 03/28/2024] [Indexed: 04/25/2024]
Abstract
Despite progress in bone tissue engineering, reconstruction of large bone defects remains an important clinical challenge. Here, a biomaterial designed to recruit bone cells, endothelial cells, and neuronal fibers within the same matrix is developed, enabling bone tissue regeneration. The bioactive matrix is based on modified elastin-like polypeptides (ELPs) grafted with laminin-derived adhesion peptides IKVAV and YIGSR, and the SNA15 peptide for retention of hydroxyapatite (HA) particles. The composite matrix shows suitable porosity, interconnectivity, biocompatibility for endothelial cells, and the ability to support neurites outgrowth by sensory neurons. Subcutaneous implantation leads to the formation of osteoid tissue, characterized by the presence of bone cells, vascular networks, and neuronal structures, while minimizing inflammation. Using a rat femoral condyle defect model, longitudinal micro-CT analysis is performed, which demonstrates a significant increase in the volume of mineralized tissue when using the ELP-based matrix compared to empty defects and a commercially available control (Collapat). Furthermore, visible blood vessel networks and nerve fibers are observed within the lesions after a period of two weeks. By incorporating multiple key components that support cell growth, mineralization, and tissue integration, this ELP-based composite matrix provides a holistic and versatile solution to enhance bone tissue regeneration.
Collapse
Affiliation(s)
- Nadia Mahmoudi
- Tissue Bioengineering Laboratory (BioTis), Inserm U1026, University of Bordeaux, Bordeaux, France
| | - Micaela Roque
- Tissue Bioengineering Laboratory (BioTis), Inserm U1026, University of Bordeaux, Bordeaux, France
| | - Bruno Paiva Dos Santos
- Tissue Bioengineering Laboratory (BioTis), Inserm U1026, University of Bordeaux, Bordeaux, France
| | - Hugo Oliveira
- Tissue Bioengineering Laboratory (BioTis), Inserm U1026, University of Bordeaux, Bordeaux, France
| | - Robin Siadous
- Tissue Bioengineering Laboratory (BioTis), Inserm U1026, University of Bordeaux, Bordeaux, France
| | - Sylvie Rey
- Tissue Bioengineering Laboratory (BioTis), Inserm U1026, University of Bordeaux, Bordeaux, France
| | | | | | - Sylvain Catros
- CHU Bordeaux, Dentistry and Oral Health Department, Bordeaux, 33076, France
| | - Bertrand Garbay
- Univ. Bordeaux, CNRS, Bordeaux INP, LCPO, UMR, Pessac, 5629, France
| | | |
Collapse
|
2
|
Zhang YD, Ma AB, Sun L, Chen JD, Hong G, Wu HK. Nanoclay-Modified Hyaluronic Acid Microspheres for Bone Induction by Sustained rhBMP-2 Delivery. Macromol Biosci 2024; 24:e2300245. [PMID: 37572308 DOI: 10.1002/mabi.202300245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 07/12/2023] [Indexed: 08/14/2023]
Abstract
Microspheres (MSs) are ideal candidates as biological scaffolds loading with growth factors or cells for bone tissue engineering to repair irregular alveolar bone defects by minimally invasive injection. However, the high initial burst release of growth factor and low cell attachment limit the application of microspheres. The modification of microspheres often needs expensive experiments facility or complex chemical reactions, which is difficult to achieve and may bring other problems. In this study, a sol-grade nanoclay, laponite XLS is used to modify the surface of MSs to enhance its affinity to either positively or negatively charged proteins and cells without changing the interior structure of the MSs. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is used as a representation of growth factor to check the osteoinduction ability of laponite XLS-modified MSs. By modification, the protein sustained release, cell loading, and osteoinduction ability of MSs are improved. Modified by 1% laponite XLS, the MSs can not only promote osteogenic differentiation of MC3T3-E1 cells by themselves, but also enhance the effect of the rhBMP-2 below the effective dose. Collectively, the study provides an easy and viable method to modify the biological behavior of microspheres for bone tissue regeneration.
Collapse
Affiliation(s)
- Yi-Ding Zhang
- Division for Globalization Initiative, Liaison Center for Innovative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, Section 3, South Renmin Road, Chengdu, Sichuan, 610041, P. R. China
| | - Ao-Bo Ma
- Division for Globalization Initiative, Liaison Center for Innovative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan
| | - Lu Sun
- Division for Globalization Initiative, Liaison Center for Innovative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan
| | - Jun-Duo Chen
- Division for Globalization Initiative, Liaison Center for Innovative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan
| | - Guang Hong
- Division for Globalization Initiative, Liaison Center for Innovative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan
- Department of Prosthodontics, Faculty of Dental Medicine, Airlangga University, Surabaya, 60115, Indonesia
| | - Hong-Kun Wu
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, Section 3, South Renmin Road, Chengdu, Sichuan, 610041, P. R. China
| |
Collapse
|
3
|
Ahmed Omar N, Roque J, Galvez P, Siadous R, Chassande O, Catros S, Amédée J, Roques S, Durand M, Bergeaut C, Bidault L, Aprile P, Letourneur D, Fricain JC, Fenelon M. Development of Novel Polysaccharide Membranes for Guided Bone Regeneration: In Vitro and In Vivo Evaluations. Bioengineering (Basel) 2023; 10:1257. [PMID: 38002381 PMCID: PMC10669683 DOI: 10.3390/bioengineering10111257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 10/16/2023] [Accepted: 10/20/2023] [Indexed: 11/26/2023] Open
Abstract
INTRODUCTION Guided bone regeneration (GBR) procedures require selecting suitable membranes for oral surgery. Pullulan and/or dextran-based polysaccharide materials have shown encouraging results in bone regeneration as bone substitutes but have not been used to produce barrier membranes. The present study aimed to develop and characterize pullulan/dextran-derived membranes for GBR. MATERIALS AND METHODS Two pullulan/dextran-based membranes, containing or not hydroxyapatite (HA) particles, were developed. In vitro, cytotoxicity evaluation was performed using human bone marrow mesenchymal stem cells (hBMSCs). Biocompatibility was assessed on rats in a subcutaneous model for up to 16 weeks. In vivo, rat femoral defects were created on 36 rats to compare the two pullulan/dextran-based membranes with a commercial collagen membrane (Bio-Gide®). Bone repair was assessed radiologically and histologically. RESULTS Both polysaccharide membranes demonstrated cytocompatibility and biocompatibility. Micro-computed tomography (micro-CT) analyses at two weeks revealed that the HA-containing membrane promoted a significant increase in bone formation compared to Bio-Gide®. At one month, similar effects were observed among the three membranes in terms of bone regeneration. CONCLUSION The developed pullulan/dextran-based membranes evidenced biocompatibility without interfering with bone regeneration and maturation. The HA-containing membrane, which facilitated early bone regeneration and offered adequate mechanical support, showed promising potential for GBR procedures.
Collapse
Affiliation(s)
- Naïma Ahmed Omar
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
| | - Jéssica Roque
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
| | - Paul Galvez
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
| | - Robin Siadous
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
| | - Olivier Chassande
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
| | - Sylvain Catros
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
- Department of Oral Surgery, University Hospital of Bordeaux, F-33076 Bordeaux, France
| | - Joëlle Amédée
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
| | - Samantha Roques
- Centre d’Investigation Clinique de Bordeaux (CIC 1401), University Hospital of Bordeaux, INSERM, F-33000 Bordeaux, France (M.D.)
| | - Marlène Durand
- Centre d’Investigation Clinique de Bordeaux (CIC 1401), University Hospital of Bordeaux, INSERM, F-33000 Bordeaux, France (M.D.)
| | - Céline Bergeaut
- Siltiss, SA, Zac de la Nau, 19240 Saint-Viance, France; (C.B.); (L.B.)
| | - Laurent Bidault
- Siltiss, SA, Zac de la Nau, 19240 Saint-Viance, France; (C.B.); (L.B.)
| | - Paola Aprile
- Laboratory for Vascular Translational Science (LVTS), X Bichat Hospital, University Paris Cité & University Sorbonne Paris Nord, INSERM 1148, F-75018 Paris, France
| | - Didier Letourneur
- Siltiss, SA, Zac de la Nau, 19240 Saint-Viance, France; (C.B.); (L.B.)
- Laboratory for Vascular Translational Science (LVTS), X Bichat Hospital, University Paris Cité & University Sorbonne Paris Nord, INSERM 1148, F-75018 Paris, France
| | - Jean-Christophe Fricain
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
- Department of Oral Surgery, University Hospital of Bordeaux, F-33076 Bordeaux, France
- Centre d’Investigation Clinique de Bordeaux (CIC 1401), University Hospital of Bordeaux, INSERM, F-33000 Bordeaux, France (M.D.)
| | - Mathilde Fenelon
- Laboratory for Tissue Bioengineering, University of Bordeaux, INSERM 1026, F-33076 Bordeaux, France; (N.A.O.); (O.C.); (M.F.)
- Department of Oral Surgery, University Hospital of Bordeaux, F-33076 Bordeaux, France
| |
Collapse
|
4
|
Sivakumar PM, Yetisgin AA, Demir E, Sahin SB, Cetinel S. Polysaccharide-bioceramic composites for bone tissue engineering: A review. Int J Biol Macromol 2023; 250:126237. [PMID: 37567538 DOI: 10.1016/j.ijbiomac.2023.126237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 07/05/2023] [Accepted: 08/07/2023] [Indexed: 08/13/2023]
Abstract
Limitations associated with conventional bone substitutes such as autografts, increasing demand for bone grafts, and growing elderly population worldwide necessitate development of unique materials as bone graft substitutes. Bone tissue engineering (BTE) would ensure therapy advancement, efficiency, and cost-effective treatment modalities of bone defects. One way of engineering bone tissue scaffolds by mimicking natural bone tissue composed of organic and inorganic phases is to utilize polysaccharide-bioceramic hybrid composites. Polysaccharides are abundant in nature, and present in human body. Biominerals, like hydroxyapatite are present in natural bone and some of them possess osteoconductive and osteoinductive properties. Ion doped bioceramics could substitute protein-based biosignal molecules to achieve osteogenesis, vasculogenesis, angiogenesis, and stress shielding. This review is a systemic summary on properties, advantages, and limitations of polysaccharide-bioceramic/ion doped bioceramic composites along with their recent advancements in BTE.
Collapse
Affiliation(s)
- Ponnurengam Malliappan Sivakumar
- Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey; Institute of Research and Development, Duy Tan University, Da Nang 550000, Viet Nam; School of Medicine and Pharmacy, Duy Tan University, Da Nang 550000, Viet Nam.
| | - Abuzer Alp Yetisgin
- Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey; Sabanci University, Faculty of Engineering and Natural Sciences, Materials Science and Nano-Engineering Program, Istanbul 34956, Turkey
| | - Ebru Demir
- Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey; Sabanci University, Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Program, Istanbul 34956, Turkey
| | - Sevilay Burcu Sahin
- Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey; Sabanci University, Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Program, Istanbul 34956, Turkey
| | - Sibel Cetinel
- Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey; Sabanci University, Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Program, Istanbul 34956, Turkey.
| |
Collapse
|
5
|
Pullulan in pharmaceutical and cosmeceutical formulations: A review. Int J Biol Macromol 2023; 231:123353. [PMID: 36681225 DOI: 10.1016/j.ijbiomac.2023.123353] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 01/05/2023] [Accepted: 01/16/2023] [Indexed: 01/19/2023]
Abstract
Pullulan, an α-glucan polysaccharide, is colorless, odorless, non-toxic, non-carcinogenic, highly biocompatible, edible and biodegradable in nature. The long chains of glucopyranose rings in pullulan structure are linked together by α-(1 → 4) and α-(1 → 6) glycosidic linkages. The occurrence of both glycosidic linkages in the pullulan structure contributes to its distinctive properties. The unique structure of pullulan makes it a potent candidate for both pharmaceutical and cosmeceutical applications. In pharmaceuticals, it can be used as a drug carrier and in various dosage formulations. It has been widely used in drug targeting, implants, ocular dosage forms, topical formulations, oral dosage forms, and oral liquid formulations, etc. Pullulan can be used as a potential carrier of active ingredients and their site-specific delivery to skin layers for cosmeceutical applications. It has been extensively used in cosmeceutical formulations like creams, shampoo, lotions, sunscreen, facial packs, etc. The current review highlights applications of pullulan in pharmaceutical and cosmeceutical applications.
Collapse
|
6
|
Bone Regeneration in Small and Large Segmental Bone Defect Models after Radiotherapy Using Injectable Polymer-Based Biodegradable Materials Containing Strontium-Doped Hydroxyapatite Particles. Int J Mol Sci 2023; 24:ijms24065429. [PMID: 36982504 PMCID: PMC10049363 DOI: 10.3390/ijms24065429] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Revised: 02/26/2023] [Accepted: 03/07/2023] [Indexed: 03/14/2023] Open
Abstract
The reconstruction of bones following tumor excision and radiotherapy remains a challenge. Our previous study, performed using polysaccharide-based microbeads that contain hydroxyapatite, found that these have osteoconductivity and osteoinductive properties. New formulations of composite microbeads containing HA particles doped with strontium (Sr) at 8 or 50% were developed to improve their biological performance and were evaluated in ectopic sites. In the current research, we characterized the materials by phase-contrast microscopy, laser dynamic scattering particle size-measurements and phosphorus content, before their implantation into two different preclinical bone defect models in rats: the femoral condyle and the segmental bone. Eight weeks after the implantation in the femoral condyle, the histology and immunohistochemistry analyses showed that Sr-doped matrices at both 8% and 50% stimulate bone formation and vascularization. A more complex preclinical model of the irradiation procedure was then developed in rats within a critical-size bone segmental defect. In the non-irradiated sites, no significant differences between the non-doped and Sr-doped microbeads were observed in the bone regeneration. Interestingly, the Sr-doped microbeads at the 8% level of substitution outperformed the vascularization process by increasing new vessel formation in the irradiated sites. These results showed that the inclusion of strontium in the matrix-stimulated vascularization in a critical-size model of bone tissue regeneration after irradiation.
Collapse
|
7
|
Le Guilcher C, Merlen G, Dellaquila A, Labour MN, Aid R, Tordjmann T, Letourneur D, Simon-Yarza T. Engineered human liver based on pullulan-dextran hydrogel promotes mice survival after liver failure. Mater Today Bio 2023; 19:100554. [PMID: 36756209 PMCID: PMC9900439 DOI: 10.1016/j.mtbio.2023.100554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 01/15/2023] [Accepted: 01/17/2023] [Indexed: 01/20/2023] Open
Abstract
Liver tissue engineering approaches aim to support drug testing, assistance devices, or transplantation. However, their suitability for clinical application remains unsatisfactory. Herein, we demonstrate the beneficial and biocompatible use of porous pullulan-dextran hydrogel for the self-assembly of hepatocytes and biliary-like cells into functional 3D microtissues. Using HepaRG cells, we obtained 21 days maintenance of engineered liver polarity, functional detoxification and excretion systems, as well as glycogen storage in hydrogel. Implantation on two liver lobes in mice of hydrogels containing 3800 HepaRG 3D structures of 100 μm in diameter, indicated successful engraftment and no signs of liver toxicity after one month. Finally, after acetaminophen-induced liver failure, when mice were transplanted with engineered livers on left lobe and peritoneal cavity, the survival rate at 7 days significantly increased by 31.8% compared with mice without cell therapy. These findings support the clinical potential of pullulan-dextran hydrogel for liver failure management.
Collapse
Affiliation(s)
- Camille Le Guilcher
- Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, U1148, F-75018 Paris, France,Corresponding author.
| | - Grégory Merlen
- Université Paris-Saclay, INSERM U1193, F- 94800 Villejuif, France
| | - Alessandra Dellaquila
- Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, U1148, F-75018 Paris, France
| | - Marie-Noëlle Labour
- Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, U1148, F-75018 Paris, France,ICGM, Université de Montpellier, CNRS, ENSCM, F- 34293 Montpellier, France,École Pratique des Hautes Études, Université Paris Sciences et Lettres, F-75014 Paris, France
| | - Rachida Aid
- Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, U1148, F-75018 Paris, France
| | | | - Didier Letourneur
- Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, U1148, F-75018 Paris, France,Corresponding author.
| | - Teresa Simon-Yarza
- Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, U1148, F-75018 Paris, France,Corresponding author.
| |
Collapse
|
8
|
Ahmed Omar N, Amédée J, Letourneur D, Fricain JC, Fenelon M. Recent Advances of Pullulan and/or Dextran-Based Materials for Bone Tissue Engineering Strategies in Preclinical Studies: A Systematic Review. Front Bioeng Biotechnol 2022; 10:889481. [PMID: 35845411 PMCID: PMC9280711 DOI: 10.3389/fbioe.2022.889481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Accepted: 05/23/2022] [Indexed: 12/09/2022] Open
Abstract
Bone tissue engineering (BTE) strategies are increasingly investigated to overcome the limitations of currently used bone substitutes and to improve the bone regeneration process. Among the natural polymers used for tissue engineering, dextran and pullulan appear as natural hydrophilic polysaccharides that became promising biomaterials for BTE. This systematic review aimed to present the different published applications of pullulan and dextran-based biomaterials for BTE. An electronic search in Pubmed, Scopus, and Web of Science databases was conducted. Selection of articles was performed following PRISMA guidelines. This systematic review led to the inclusion of 28 articles on the use of pullulan and/or dextran-based biomaterials to promote bone regeneration in preclinical models. Sixteen studies focused on dextran-based materials for bone regeneration, six on pullulan substitutes and six on the combination of pullulan and dextran. Several strategies have been developed to provide bone regeneration capacity, mainly through their fabrication processes (functionalization methods, cross-linking process), or the addition of bioactive elements. We have summarized here the strategies employed to use the polysaccharide scaffolds (fabrication process, composition, application usages, route of administration), and we highlighted their relevance and limitations for BTE applications.
Collapse
Affiliation(s)
| | - Joëlle Amédée
- Université de Bordeaux, INSERM U1026, BIOTIS, Bordeaux, France
| | - Didier Letourneur
- SILTISS, Saint-Viance, France
- Université Paris Cité, Université Sorbonne Paris Nord, INSERM U1148, LVTS, X Bichat Hospital, Université de Paris, Paris, France
| | - Jean-Christophe Fricain
- Université de Bordeaux, INSERM U1026, BIOTIS, Bordeaux, France
- Service de Chirurgie Orale, CHU Bordeaux, Bordeaux, France
| | - Mathilde Fenelon
- Université de Bordeaux, INSERM U1026, BIOTIS, Bordeaux, France
- Service de Chirurgie Orale, CHU Bordeaux, Bordeaux, France
- *Correspondence: Mathilde Fenelon,
| |
Collapse
|